Literature DB >> 2989507

Differential effects of sulmazole (AR-L 115 BS) on contractile force and cyclic AMP levels in canine ventricular muscle: comparison with MDL 17,043.

M Endoh, T Yanagisawa, T Morita, N Taira.   

Abstract

MDL 17,043 [1,3-dihydro-4-methyl-5-[4-(methylthio)-benzoyl]-2H-imidazol-2-one] and AR-L 115 BS [sulmazole, 2-[(2-methoxy-4-methylsulfinyl)phenyl]-1H-imidazo[4,5-b] pyridine] produced substantial positive inotropic effects in a concentration-dependent manner (10(-5) to 10(-3) M) in the isolated canine ventricular trabeculae in the presence of pindolol (3 X 10(-8) M). Both agents exhibited equal potency and intrinsic activity in this preparation. The time to peak tension, relaxation time and total duration of contraction were shortened by MDL 17,043 in a concentration-dependent manner up to the highest concentrations tested (10(-3) M). In contrast, AR-L 115 BS shortened these times in concentrations of 3 X 10(-4) M and lower, but prolonged them in higher concentrations. The positive inotropic effects of MDL 17,043 and AR-L 115 BS were associated with increases in the cyclic AMP levels of the muscles. The time course of the increase in cyclic AMP levels differed for the two drugs. The elevation in cyclic AMP and the positive inotropic effect produced by MDL 17,043 followed a similar time course. By contrast, the rise in the cyclic AMP level became significant only after the positive inotropic effect produced by AR-L 115 BS had reached a steady level. Carbachol, a muscarinic agonist, converted the positive inotropic effect of 10(-3) M MDL 17,043 into a negative inotropic effect, but did not alter the positive inotropic effect of 10(-3) M AR-L 115 BS.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2989507

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  12 in total

1.  Subcellular mechanism of the positive inotropic effect of a new quinolinone derivative OPC-8490 on the dog ventricular myocardium.

Authors:  M Endoh; H Satoh; I Norota; K Hirano; T Hosokawa
Journal:  Heart Vessels       Date:  1991       Impact factor: 2.037

Review 2.  Enoximone. A review of its pharmacological properties and therapeutic potential.

Authors:  M W Vernon; R C Heel; R N Brogden
Journal:  Drugs       Date:  1991-12       Impact factor: 9.546

3.  Evaluation of activity inotropic of a new steroid derivative using an isolated rat heart model.

Authors:  Figueroa-Valverde Lauro; Díaz-Cedillo Francisco; García-Cervera Elodia; Pool-Gómez Eduardo; López-Ramos Maria; Rosas-Nexticapa Marcela; Hau-Heredia Lenin; Sarabia-Alcocer Bety; Campos-Ramos Landy
Journal:  Int J Clin Exp Med       Date:  2014-05-15

4.  The new phosphodiesterase inhibitor enoximone in patients following cardiac surgery--pharmacokinetics and influence on parameters of coagulation.

Authors:  J Boldt; D Kling; H A Dieterich; P Marck; G Hempelmann
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

5.  Regulation of force and intracellular calcium transients by cyclic AMP generated by forskolin, MDL 17,043 and isoprenaline, and its modulation by muscarinic receptor agents: a novel mechanism for accentuated antagonism.

Authors:  M Endoh
Journal:  Basic Res Cardiol       Date:  1989       Impact factor: 17.165

6.  Cardiotonic actions of selective phosphodiesterase inhibitors in rat isolated ventricular cardiomyocytes.

Authors:  E J Kelso; B J McDermott; B Silke
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

7.  Effects of OPC-8212, a new positive inotropic agent, on canine ventricular arrhythmias.

Authors:  K Hashimoto; H Mitsuhashi
Journal:  Br J Pharmacol       Date:  1986-08       Impact factor: 8.739

8.  Cardiac and coronary vasodilator profile of pimobendan, a new cardiotonic drug, revealed by use of isolated, blood-perfused dog heart preparations.

Authors:  J Imagawa; K Satoh; N Taira
Journal:  Heart Vessels       Date:  1987       Impact factor: 2.037

9.  An analysis of the mechanism of the inotropic action of some milrinone analogues in guinea-pig isolated atria.

Authors:  P Dorigo; R M Gaion; P Belluco; L Mosti; P A Borea; I Maragno
Journal:  Br J Pharmacol       Date:  1991-12       Impact factor: 8.739

10.  Effects of a new 1,3-thiazole derivative ZSY-39 on force of contraction and cyclic AMP content in canine ventricular muscle.

Authors:  M Endoh; H Satoh; I Norota; K Hirano
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.